- Home
- SUIG vs PALI Comparison
SUIG vs PALI Comparison
Compare SUIG & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUIG
- PALI
- Stock Information
- Founded
- SUIG 2006
- PALI 1996
- Country
- SUIG United States
- PALI United States
- Employees
- SUIG N/A
- PALI N/A
- Industry
- SUIG Finance Companies
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SUIG Finance
- PALI Health Care
- Exchange
- SUIG Nasdaq
- PALI Nasdaq
- Market Cap
- SUIG 250.4M
- PALI 212.0M
- IPO Year
- SUIG N/A
- PALI N/A
- Fundamental
- Price
- SUIG $3.30
- PALI $1.85
- Analyst Decision
- SUIG Strong Buy
- PALI Strong Buy
- Analyst Count
- SUIG 2
- PALI 2
- Target Price
- SUIG $5.75
- PALI $12.00
- AVG Volume (30 Days)
- SUIG 1.6M
- PALI 19.0M
- Earning Date
- SUIG 11-11-2025
- PALI 11-11-2025
- Dividend Yield
- SUIG N/A
- PALI N/A
- EPS Growth
- SUIG 619.34
- PALI N/A
- EPS
- SUIG 0.24
- PALI N/A
- Revenue
- SUIG $3,305,884.00
- PALI N/A
- Revenue This Year
- SUIG N/A
- PALI N/A
- Revenue Next Year
- SUIG N/A
- PALI N/A
- P/E Ratio
- SUIG $13.92
- PALI N/A
- Revenue Growth
- SUIG 1.77
- PALI N/A
- 52 Week Low
- SUIG $1.13
- PALI $0.53
- 52 Week High
- SUIG $8.66
- PALI $3.54
- Technical
- Relative Strength Index (RSI)
- SUIG N/A
- PALI 61.19
- Support Level
- SUIG N/A
- PALI $1.61
- Resistance Level
- SUIG N/A
- PALI $1.78
- Average True Range (ATR)
- SUIG 0.00
- PALI 0.21
- MACD
- SUIG 0.00
- PALI -0.04
- Stochastic Oscillator
- SUIG 0.00
- PALI 40.28
About SUIG Sui Group Holdings Limited Common Stock
Sui Group Holdings Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.